Tango Therapeutics TNGX Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
Based on trailing twelve months.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's free cash flow margin?
- Tango Therapeutics (TNGX) reported free cash flow margin of -250.1% in Q1 2026.
- How has Tango Therapeutics's free cash flow margin changed year-over-year?
- Tango Therapeutics's free cash flow margin increased by 24.6% year-over-year, from -331.7% to -250.1%.
- What is the long-term trend for Tango Therapeutics's free cash flow margin?
- Over 4 years (2021 to 2025), Tango Therapeutics's free cash flow margin has grown at a 7.9% compound annual growth rate (CAGR), from -165.7% to -224.3%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.